Plan your trading with the latest market research on Crypto, Forex, Stocks, and more, from our team of experts.
The structural picture for oil has shifted in just over a week. When we last covered Brent on April 23,…
The S&P 500 is heading into one of the most catalyst-dense sessions of 2026. The FOMC decision lands later today,…
The Nikkei 225 has broken above 60,000 for the first time ever, completing a remarkable round trip from its mid-March…
Bitcoin rose 2.5% last week, marking a fourth straight weekly gain. The price of BTC recovered from a weekly low…
Weekly Recap: US Global stocks recap US stocks ended last week broadly higher, with both the S&P 500 and the Nasdaq…
US stocks ended last week broadly higher, with both the S&P 500 and the Nasdaq reaching record highs. Positive economic…
Key takeaways Bitcoin is testing the $79K resistance zone after a strong rally from the late-March lows around $66K. The…
Gold is still down around 10% since the Iran war began, even as the conflict has entered its most escalated…
Brent crude is grinding back toward the $100 handle, with price now trading close to where it was before Iran’s…
Bitcoin has climbed above $78,000, reaching an 11-week high after President Trump announced an indefinite extension of the US-Iran ceasefire. …
The S&P 500 has posted an impressive V-shaped recovery, retracing from below 6,400 to fresh all-time highs above 7,100 in…
Ethereum is showing signs of life for the first time this year. After months of weakness, ETF flows are returning,…
Weekly recap: US Global stocks recap US stocks rallied for a third straight week, with the S&P 500 and the…
Weekly recap: US stocks rallied for a third straight week, with the S&P 500 and the NASDAQ reaching fresh record…
The information provided here is not an invitation to buy or sell products, nor is it an invitation to make an investment or trading strategy. This should not be seen as financial or investment advice of any kind, nor does Prime XBT endorse or guarantee the relevance, timeliness, or accuracy of the information or publications.
Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.
